Skip to main content
Premium Trial:

Request an Annual Quote

MDS Pharma, Caprion, Gentris, MGH, Partner on Biomarker Discovery Services

NEW YORK, June 17 (GenomeWeb News) - Caprion Pharmaceuticals, Gentris, Massachusetts General Hospital Department of Radiology, and MDS Pharma Services have founded the Biomarker Alliance, which will offer the members' biomarker discovery services, the organization said yesterday.


Customers will have access to Caprion's protein biomarker services, Gentris' clinical pharmacogenomic services, MGH's imaging biomarker technology, and MDS Pharma Services' biomarker discovery.


In a statment, the alliance members said that they have created "the only organization providing single-point access to proteomics, pharmacogenomics, imaging, assay development and clinical testing" together in a single service


MDS Pharma Services, which spearheaded the formation of the partnership, will also manage access to the group's services.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.